A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Study NCT00022672 Information provided by Hoffmann-La Roche

First Received: August 10, 2001 Last Updated: September 16, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2006
Estimated Primary Completion Date:	No date given